In the June 10 issue of The ASCO Post, the article "Anti–PD-1 Inhibitor Gains Foothold in Merkel Cell Carcinoma," a photo labeled Paul Nghiem, MD, PhD, is incorrect. The photo that was printed is Paul Nguyen, MD, of the Dana-Farber Cancer Institute.
A photo of Dr. Nghiem is shown here.
Paul Nghiem, MD, PhD
Dr. Nghiem is the George F. Odland Chair in Dermatology, Head of University of Washington (UW), Dermatology, and UW Professor of Dermatology/Medicine. He has a particular interest in Merkel cell carcinoma. Dr. Nghiem presented abstract CT096 at the AACR Annual Meeting on April 19, 2016. The title of the abstract was “Clinical activity, immune and viral correlates of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma.”
The ASCO Post apologizes to Dr. Nghiem and Dr. Nguyen for this error.
Note that the online version of this article includes the correct photo of Dr. Nghiem and may be viewed at: www.ascopost.com/issues/june-10-2016/anti-pd-1-inhibitor-gains-foothold-in-merkel-cell-carcinoma/ ■
